JP Morgan Chase
DAWN

JP Morgan Chase’s Day One Biopharmaceuticals DAWN Stock Holding History

JP Morgan Chase’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-190,000
Closed -$4.07M – 7807
2026
Q1 		$4.07M Buy
+190,000
New +$2.68M ﹤0.01% 3509

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's DAWN Position: Q2 2026 in Review

JP Morgan Chase sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 3,134,753 shares — an estimated $67.1M sold.

JP Morgan Chase first reported a position in DAWN in Q2 2021 and held it in 20 quarters. The position peaked at $67.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • JP Morgan Chase reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 3,134,753 Day One Biopharmaceuticals shares in Q2 2026, an estimated $67.1M.
  • JP Morgan Chase first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 20 quarters.
  • JP Morgan Chase's Day One Biopharmaceuticals position peaked at $67.1M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.